The W. M. Keck Foundation has awarded research duo Catherine Galbraith, Ph.D., and James Galbraith, Ph.D., $1 million over three years to develop a one-of-a-kind imaging and computational system. Their system will seek to decode molecular aggregates — collections of proteins or ribonucleic acid that frequently rearrange inside cells and are involved in cellular information processing.
Nevaeh was diagnosed with Alport Syndrome, a rare genetic disorder that causes kidney disease. Hear from Nevaeh about her experience at Doernbecher and her hopes for the future.
This holiday season, we celebrate you and the spirit of giving that makes a difference in people’s lives. We’ve gathered a few of the heartwarming, inspiring stories this past year made possible by people like you.
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Dr. Pennesi led the first-ever CRISPR gene-editing procedure within the human body, which is showing promising results. We asked him four questions about his research and what this breakthrough could mean.
Penelope was born with a rare blood disorder. When complication after complication hit, her family turned to OHSU Doernbecher Children’s Hospital, who helped her family through a complex diagnosis.
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
